Cresco Labs Inc. (CRLBF)
(Delayed Data from OTC)
$1.91 USD
+0.09 (4.95%)
Updated May 31, 2024 03:59 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Brokerage Reports
0 items in cart
Cresco Labs Inc. [CRLBF]
Reports for Purchase
Showing records 81 - 100 ( 128 total )
Company: Cresco Labs Inc.
Industry: Medical - Products
Weekly ReHash: Pricing is Key to Improving Industry Fundamentals
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Cresco Labs Inc.
Industry: Medical - Products
Cannabis Industry Update: 2022 Performance and Valuations
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Cresco Labs Inc.
Industry: Medical - Products
Weekly ReHash: Putting 2022 Performance & Valuations Behind Us
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Cresco Labs Inc.
Industry: Medical - Products
Company: Cresco Labs Inc.
Industry: Medical - Products
Initiating Coverage at Outperform: Room to Go for Cresco
Provider: Wedbush Securities Inc.
Analyst: Research Department
Company: Cresco Labs Inc.
Industry: Medical - Products
Initiating Coverage of U.S. Cannabis: Setting Stage for Greener Pastures
Provider: Wedbush Securities Inc.
Analyst: Research Department
Company: Cresco Labs Inc.
Industry: Medical - Products
Weekly ReHash: 3Q Cannabis Earnings Recap, Inflationary Pressures Impacting NT
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Cresco Labs Inc.
Industry: Medical - Products
Q322 Challenging as Wholesale Price Pressure Continues
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Cresco Labs Inc.
Industry: Medical - Products
Q3 Revenue in-line, CCHW Acquisition Remains on Track
Provider: VENTUM CAPITAL MARKETS
Analyst: ZANDBERG J
Company: Cresco Labs Inc.
Industry: Medical - Products
Company: Cresco Labs Inc.
Industry: Medical - Products
Company: Cresco Labs Inc.
Industry: Medical - Products
Company: Cresco Labs Inc.
Industry: Medical - Products
Cresco and CC Sell Assets in Three States to Sean "Diddy" Combs
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Cresco Labs Inc.
Industry: Medical - Products
Weekly ReHash: Mid-Term Election Impact on Cannabis Adding New Adult-Use States
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Cresco Labs Inc.
Industry: Medical - Products
Q3 Fundamentals Appear Soft but Legislative Reform Looks Promising
Provider: VENTUM CAPITAL MARKETS
Analyst: ZANDBERG J
Company: Cresco Labs Inc.
Industry: Medical - Products
Cannabis Industry Update: 3Q22 Earnings - Week I Preview
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Cresco Labs Inc.
Industry: Medical - Products
Weekly ReHash: Regulatory Steps to Normalize Cannabis, Explicit Safe Harbor Key
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Cresco Labs Inc.
Industry: Medical - Products
Weekly ReHash: Regulatory Steps to Normalize Cannabis, Explicit Safe Harbor Key
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Cresco Labs Inc.
Industry: Medical - Products
Weekly Rehash: Cannabis Equity Returns in a Historical Context
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Cresco Labs Inc.
Industry: Medical - Products
Weekly ReHash: Canada Update, Sales & Pricing Stabilizing
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S